H.R. 3282 · 118th Congress (2023–2025)
Promoting Transparency and Healthy Competition in Medicare Act
This bill requires Medicare Advantage (MA) organizations and prescription drug plan (PDP) sponsors and pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit to report certain information relating to their ownership interests in participating providers.
Specifically, MA organizations must report on items and services, patient risk scores and associated diagnoses, prior authorization requests, and incentive payments with respect to providers in which the MA organization has an ownership interest as compared to other providers.
Similarly, PDP sponsors under the Medicare prescription drug benefit must report on the prices of prescription drugs with respect to pharmacies in which the PDP sponsor has an ownership interest as compared to other pharmacies. The bill also prohibits PDP sponsors from contracting with PBMs in which the PDP sponsor has an ownership interest unless the PBM reports certain information on rebates and payments between the PBM, PDP sponsor, pharmacies, and drug manufacturers.
Show official title
To amend title XVIII of the Social Security Act to promote transparency of common ownership interests under parts C and D of the Medicare program.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 3282’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Diana Harshbarger (R-TN-1)
- Cosponsors
3 cosponsors
3 original · 0 later
- Rep. Gus M. Bilirakis (R-FL-12)· Original · May 15, 2023
- Rep. Janice D. Schakowsky (D-IL-9)· Original · May 15, 2023
- Rep. Kim Schrier (D-WA-8)· Original · May 15, 2023
- Policy area
- Health
- Subjects
- Government information and archives
- Health care costs and insurance
- Health information and medical records
- Medicare
- Prescription drugs
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 3 committee actions · May 15, 2023 – Dec 17, 2024
Referred to committee
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
May 17, 2023 · Meeting
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Promoting Transparency and Healthy Competition in Medicare Act
Display title, Short title · Introduced in House
To amend title XVIII of the Social Security Act to promote transparency of common ownership interests under parts C and D of the Medicare program.
Official title · Introduced in House